Magellan Health Return on Equity

Magellan Health (MGLN) currently reports a ROE of 15.62%. That is below the Healthcare sector average of 21.28%. Use the charts on this page to explore Magellan Health's ROE history and peer comparisons.

Magellan Health's ROE of 15.62% is lower than the Healthcare sector average of 21.28%. That is roughly 26.6% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Magellan Health's current 15.62% should be judged against Healthcare norms (sector average: 21.28%) and against MGLN's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of 15.62%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 21.28%. From there, open related valuation or income-statement pages for Magellan Health, and consider following MGLN for alerts when major investors trade the stock.

Magellan Health is classified in the Healthcare sector. On ROE, it currently shows 15.62% versus a sector average near 21.28%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing MGLN with unrelated industries.